Neuronal Signalling Pathways Controlling Axon Growth and Regeneration

Andrew John Murray, Derryck Shewan

Research output: Contribution to conferencePoster

Abstract

The search for an effective therapy for repairing the damaged central nervous system (CNS) remains one of the greatest challenges facing medical science. Damage to the brain or spinal cord is so debilitating because the adult mammalian CNS does not regenerate after injury. However, the immature nervous system can regenerate, and thus the ability of neurons to regrow their axonal processes is only lost around birth. A number of reasons have been proposed for this developmental decline in regenerative capacity. Cyclic-adenosine monophosphate (cAMP) is an important intracellular signalling molecule known to be involved in neuronal responses to a number of axon growth-promoting and inhibitory guidance cues. Endogenous levels of cAMP decline at the time the nervous system loses its regenerative capacity. Artificial elevation of cAMP activity can overcome growth-inhibitory signals and enhance axon outgrowth. Thus an increase in cAMP activity appears to encourage older neurons to behave like their younger counterparts in regenerating axons.

However, the signalling mechanisms activated by cAMP to induce axon regeneration are not well understood. cAMP is known to have two direct intracellular targets, protein kinase A (PKA) and the recently characterised exchange protein activated by cAMP (Epac). Previous studies have indicated that PKA controls cAMP’s growth promoting ability. However, using selective cAMP agonists and siRNA techniques we have found that cAMP’s activation of Epac is critical to increase axon growth and regeneration, and direct Epac activation can be more effective at inducing regeneration than cAMP elevation. Furthermore, we have found that Epac and PKA mediate distinct aspects of axon growth. These results provide further characterisation of the neuronal signalling pathways that can be targeted to induce axon regeneration and provide further optimism for a future therapeutic strategy.
Original languageEnglish
Publication statusPublished - 31 Aug 2007
EventScottish Neuroscience Group Annual Meeting (2007) - Edinburgh, United Kingdom
Duration: 31 Aug 2007 → …

Conference

ConferenceScottish Neuroscience Group Annual Meeting (2007)
CountryUnited Kingdom
CityEdinburgh
Period31/08/07 → …

Fingerprint

Cyclic AMP
Axons
Regeneration
Growth
Cyclic AMP-Dependent Protein Kinases
Aptitude
Nervous System
Proteins
Central Nervous System
Neurons
Small Interfering RNA
Cues
Spinal Cord
Parturition
Wounds and Injuries
Brain
Therapeutics

Cite this

Murray, A. J., & Shewan, D. (2007). Neuronal Signalling Pathways Controlling Axon Growth and Regeneration. Poster session presented at Scottish Neuroscience Group Annual Meeting (2007), Edinburgh, United Kingdom.

Neuronal Signalling Pathways Controlling Axon Growth and Regeneration. / Murray, Andrew John; Shewan, Derryck.

2007. Poster session presented at Scottish Neuroscience Group Annual Meeting (2007), Edinburgh, United Kingdom.

Research output: Contribution to conferencePoster

Murray, AJ & Shewan, D 2007, 'Neuronal Signalling Pathways Controlling Axon Growth and Regeneration' Scottish Neuroscience Group Annual Meeting (2007), Edinburgh, United Kingdom, 31/08/07, .
Murray AJ, Shewan D. Neuronal Signalling Pathways Controlling Axon Growth and Regeneration. 2007. Poster session presented at Scottish Neuroscience Group Annual Meeting (2007), Edinburgh, United Kingdom.
Murray, Andrew John ; Shewan, Derryck. / Neuronal Signalling Pathways Controlling Axon Growth and Regeneration. Poster session presented at Scottish Neuroscience Group Annual Meeting (2007), Edinburgh, United Kingdom.
@conference{d6b8fb64d4b14a2ca47f790351a82935,
title = "Neuronal Signalling Pathways Controlling Axon Growth and Regeneration",
abstract = "The search for an effective therapy for repairing the damaged central nervous system (CNS) remains one of the greatest challenges facing medical science. Damage to the brain or spinal cord is so debilitating because the adult mammalian CNS does not regenerate after injury. However, the immature nervous system can regenerate, and thus the ability of neurons to regrow their axonal processes is only lost around birth. A number of reasons have been proposed for this developmental decline in regenerative capacity. Cyclic-adenosine monophosphate (cAMP) is an important intracellular signalling molecule known to be involved in neuronal responses to a number of axon growth-promoting and inhibitory guidance cues. Endogenous levels of cAMP decline at the time the nervous system loses its regenerative capacity. Artificial elevation of cAMP activity can overcome growth-inhibitory signals and enhance axon outgrowth. Thus an increase in cAMP activity appears to encourage older neurons to behave like their younger counterparts in regenerating axons. However, the signalling mechanisms activated by cAMP to induce axon regeneration are not well understood. cAMP is known to have two direct intracellular targets, protein kinase A (PKA) and the recently characterised exchange protein activated by cAMP (Epac). Previous studies have indicated that PKA controls cAMP’s growth promoting ability. However, using selective cAMP agonists and siRNA techniques we have found that cAMP’s activation of Epac is critical to increase axon growth and regeneration, and direct Epac activation can be more effective at inducing regeneration than cAMP elevation. Furthermore, we have found that Epac and PKA mediate distinct aspects of axon growth. These results provide further characterisation of the neuronal signalling pathways that can be targeted to induce axon regeneration and provide further optimism for a future therapeutic strategy.",
author = "Murray, {Andrew John} and Derryck Shewan",
year = "2007",
month = "8",
day = "31",
language = "English",
note = "Scottish Neuroscience Group Annual Meeting (2007) ; Conference date: 31-08-2007",

}

TY - CONF

T1 - Neuronal Signalling Pathways Controlling Axon Growth and Regeneration

AU - Murray, Andrew John

AU - Shewan, Derryck

PY - 2007/8/31

Y1 - 2007/8/31

N2 - The search for an effective therapy for repairing the damaged central nervous system (CNS) remains one of the greatest challenges facing medical science. Damage to the brain or spinal cord is so debilitating because the adult mammalian CNS does not regenerate after injury. However, the immature nervous system can regenerate, and thus the ability of neurons to regrow their axonal processes is only lost around birth. A number of reasons have been proposed for this developmental decline in regenerative capacity. Cyclic-adenosine monophosphate (cAMP) is an important intracellular signalling molecule known to be involved in neuronal responses to a number of axon growth-promoting and inhibitory guidance cues. Endogenous levels of cAMP decline at the time the nervous system loses its regenerative capacity. Artificial elevation of cAMP activity can overcome growth-inhibitory signals and enhance axon outgrowth. Thus an increase in cAMP activity appears to encourage older neurons to behave like their younger counterparts in regenerating axons. However, the signalling mechanisms activated by cAMP to induce axon regeneration are not well understood. cAMP is known to have two direct intracellular targets, protein kinase A (PKA) and the recently characterised exchange protein activated by cAMP (Epac). Previous studies have indicated that PKA controls cAMP’s growth promoting ability. However, using selective cAMP agonists and siRNA techniques we have found that cAMP’s activation of Epac is critical to increase axon growth and regeneration, and direct Epac activation can be more effective at inducing regeneration than cAMP elevation. Furthermore, we have found that Epac and PKA mediate distinct aspects of axon growth. These results provide further characterisation of the neuronal signalling pathways that can be targeted to induce axon regeneration and provide further optimism for a future therapeutic strategy.

AB - The search for an effective therapy for repairing the damaged central nervous system (CNS) remains one of the greatest challenges facing medical science. Damage to the brain or spinal cord is so debilitating because the adult mammalian CNS does not regenerate after injury. However, the immature nervous system can regenerate, and thus the ability of neurons to regrow their axonal processes is only lost around birth. A number of reasons have been proposed for this developmental decline in regenerative capacity. Cyclic-adenosine monophosphate (cAMP) is an important intracellular signalling molecule known to be involved in neuronal responses to a number of axon growth-promoting and inhibitory guidance cues. Endogenous levels of cAMP decline at the time the nervous system loses its regenerative capacity. Artificial elevation of cAMP activity can overcome growth-inhibitory signals and enhance axon outgrowth. Thus an increase in cAMP activity appears to encourage older neurons to behave like their younger counterparts in regenerating axons. However, the signalling mechanisms activated by cAMP to induce axon regeneration are not well understood. cAMP is known to have two direct intracellular targets, protein kinase A (PKA) and the recently characterised exchange protein activated by cAMP (Epac). Previous studies have indicated that PKA controls cAMP’s growth promoting ability. However, using selective cAMP agonists and siRNA techniques we have found that cAMP’s activation of Epac is critical to increase axon growth and regeneration, and direct Epac activation can be more effective at inducing regeneration than cAMP elevation. Furthermore, we have found that Epac and PKA mediate distinct aspects of axon growth. These results provide further characterisation of the neuronal signalling pathways that can be targeted to induce axon regeneration and provide further optimism for a future therapeutic strategy.

M3 - Poster

ER -